Suppr超能文献

相似文献

1
3
Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson's disease.
Int J Neurosci. 2022 Jul;132(7):673-688. doi: 10.1080/00207454.2020.1835899. Epub 2020 Oct 26.
4
MicroRNA Expression Profiles Identify Biomarker for Differentiating the Embolic Stroke from Thrombotic Stroke.
Biomed Res Int. 2018 Dec 6;2018:4514178. doi: 10.1155/2018/4514178. eCollection 2018.
5
Aberrant expression of microRNA-132-3p and microRNA-146a-5p in Parkinson's disease patients.
Open Life Sci. 2020 Sep 2;15(1):647-653. doi: 10.1515/biol-2020-0060. eCollection 2020.
7
Serum and Exosomal miR-7-1-5p and miR-223-3p as Possible Biomarkers for Parkinson's Disease.
Biomolecules. 2023 May 19;13(5):865. doi: 10.3390/biom13050865.
9
Differential expression of exosomal microRNAs in fresh and senescent apheresis platelet concentrates.
Platelets. 2022 Nov 17;33(8):1260-1269. doi: 10.1080/09537104.2022.2108541. Epub 2022 Aug 14.

引用本文的文献

2
Cohort-specific boolean models highlight different regulatory modules during Parkinson's disease progression.
iScience. 2024 Sep 14;27(10):110956. doi: 10.1016/j.isci.2024.110956. eCollection 2024 Oct 18.
3
Autism spectrum disorder: difficulties in diagnosis and microRNA biomarkers.
Neural Regen Res. 2025 Oct 1;20(10):2776-2786. doi: 10.4103/NRR.NRR-D-24-00712. Epub 2024 Sep 24.
5
MicroRNAs as potential diagnostic biomarkers for bipolar disorder.
Neural Regen Res. 2025 Jun 1;20(6):1681-1695. doi: 10.4103/NRR.NRR-D-23-01588. Epub 2024 Jan 31.
6
Anti-NMDA Receptor Encephalitis, Human Papillomavirus, and microRNA.
Curr Med Chem. 2025;32(4):771-787. doi: 10.2174/0109298673264615231124072130.
7
Profiling Small RNA From Brain Extracellular Vesicles in Individuals With Depression.
Int J Neuropsychopharmacol. 2024 Mar 1;27(3). doi: 10.1093/ijnp/pyae013.
8
MicroRNAs as potential biomarkers for diagnosis of schizophrenia and influence of antipsychotic treatment.
Neural Regen Res. 2024 Jul 1;19(7):1523-1531. doi: 10.4103/1673-5374.387966. Epub 2023 Nov 8.
9
MicroRNAs as potential biomarkers for diagnosis of attention deficit hyperactivity disorder.
Neural Regen Res. 2024 Mar;19(3):557-562. doi: 10.4103/1673-5374.380880.
10
MicroRNA Alterations in Chronic Traumatic Encephalopathy and Amyotrophic Lateral Sclerosis.
Front Neurosci. 2022 May 19;16:855096. doi: 10.3389/fnins.2022.855096. eCollection 2022.

本文引用的文献

1
LRRK2 is a negative regulator of phagosome maturation in macrophages.
EMBO J. 2018 Jun 15;37(12). doi: 10.15252/embj.201798694. Epub 2018 May 22.
2
Exploring microRNA Biomarker for Amyotrophic Lateral Sclerosis.
Int J Mol Sci. 2018 Apr 28;19(5):1318. doi: 10.3390/ijms19051318.
3
Identification of aberrant circulating miRNAs in Parkinson's disease plasma samples.
Brain Behav. 2018 Feb 19;8(4):e00941. doi: 10.1002/brb3.941. eCollection 2018 Apr.
4
microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches.
Int J Mol Sci. 2017 Dec 13;18(12):2698. doi: 10.3390/ijms18122698.
5
Genetic Association between Amyotrophic Lateral Sclerosis and Cancer.
Genes (Basel). 2017 Sep 27;8(10):243. doi: 10.3390/genes8100243.
6
Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles.
PLoS One. 2016 Jun 20;11(6):e0157852. doi: 10.1371/journal.pone.0157852. eCollection 2016.
7
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update.
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7. doi: 10.1093/nar/gkw377. Epub 2016 May 3.
8
microRNA Profiles in Parkinson's Disease Prefrontal Cortex.
Front Aging Neurosci. 2016 Mar 1;8:36. doi: 10.3389/fnagi.2016.00036. eCollection 2016.
10
Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.
Neurobiol Aging. 2016 Jan;37:209.e1-209.e7. doi: 10.1016/j.neurobiolaging.2015.09.014. Epub 2015 Sep 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验